A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: A predictive factor for survival?

Radiation Oncology

Volumn 9, Issue 1, 2014, Pages

  Adeberg, Sebastian ^a   Bostel, Tilman ^a   König, Laila ^a   Welzel, Thomas ^a   Debus, Juergen ^a   Combs, Stephanie E ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Glioblastoma; Long term survival; Prognostic factors; Subventricular zone

Indexed keywords

BEVACIZUMAB; CETUXIMAB; TEMOZOLOMIDE; TEMSIROLIMUS; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CHEMORADIOTHERAPY; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PICTURE ARCHIVING AND COMMUNICATION SYSTEM; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROGRESSION FREE SURVIVAL; SHORT TERM SURVIVAL; SUBVENTRICULAR ZONE; TUMOR BIOPSY; TUMOR LOCALIZATION; ADOLESCENT; BRAIN NEOPLASMS; BRAIN VENTRICLE; CANCER STAGING; CHILD; COMPARATIVE STUDY; DRUG EFFECTS; FOLLOW UP; MIDDLE AGED; MORTALITY; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; RADIATION DOSE; RADIATION RESPONSE; SURVIVAL RATE; SURVIVOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CEREBRAL VENTRICLES; CHEMORADIOTHERAPY; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; SURVIVAL RATE; SURVIVORS; YOUNG ADULT;

EID: 84899950195     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-9-95     Document Type: Article

References (23)

1. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009, 10(5):459-466. 10.1016/S1470-2045(09)70025-7, 19269895.
2. Forsyth PA, Cairncross JG. Treatment of malignant glioma in adults. Curr Opin Neurol 1995, 8(6):414-418. 10.1097/00019052-199512000-00002, 8845922.
3. Scott JN, Rewcastle NB, Brasher PM, Fulton D, MacKinnon JA, Hamilton M, Cairncross JG, Forsyth P. Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol 1999, 46(2):183-188. 10.1002/1531-8249(199908)46:2<183::AID-ANA7>3.0.CO;2-7, 10443883.
4. Smoll NR, Schaller K, Gautschi OP. Long-term survival of patients with glioblastoma multiforme (GBM). J Clin Neurosci 2013, 20(5):670-675. 10.1016/j.jocn.2012.05.040, 23352352.
5. Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, Lillehei KO, Bernstein M, Brem H, Sloan A. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 2003, 99(3):467-473. 10.3171/jns.2003.99.3.0467, 12959431.
6. Lamborn KR, Chang SM, Prados MD. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol 2004, 6(3):227-235. 10.1215/S1152851703000620, 1871999, 15279715.
7. Chaichana KL, Pendleton C, Chambless L, Camara-Quintana J, Nathan JK, Hassam-Malani L, Li G, Harsh GR, Thompson RC, Lim M. Multi-institutional validation of a preoperative scoring system which predicts survival for patients with glioblastoma. J Clin Neurosci 2013, 20(10):1422-6. 10.1016/j.jocn.2013.02.007, 23928040.
8. Hegi ME, Liu L, Herman JG, Stupp R, Wick W, Weller M, Mehta MP, Gilbert MR. Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. J Clin Oncol 2008, 26(25):4189-4199. 10.1200/JCO.2007.11.5964, 18757334.
9. Martinez R, Schackert G, Yaya-Tur R, Rojas-Marcos I, Herman JG, Esteller M. Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiforme. J Neurooncol 2007, 83(1):91-93. 10.1007/s11060-006-9292-0, 17164975.
10. Lim DA, Cha S, Mayo MC, Chen MH, Keles E, VandenBerg S, Berger MS. Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol 2007, 9(4):424-429. 10.1215/15228517-2007-023, 1994099, 17622647.
11. Jafri NF, Clarke JL, Weinberg V, Barani IJ, Cha S. Relationship of glioblastoma multiforme to the subventricular zone is associated with survival. Neuro Oncol 2013, 15(1):91-96. 10.1093/neuonc/nos268, 3534420, 23095230.
12. Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger G. Long-term survival with glioblastoma multiforme. Brain 2007, 130(Pt 10):2596-2606.
13. Hartmann C, Hentschel B, Simon M, Westphal M, Schackert G, Tonn JC, Loeffler M, Reifenberger G, Pietsch T, von Deimling A. Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations. Clin Cancer Res 2013, 19(18):5146-57. 10.1158/1078-0432.CCR-13-0017, 23918605.
14. Sonoda Y, Kumabe T, Watanabe M, Nakazato Y, Inoue T, Kanamori M, Tominaga T. Long-term survivors of glioblastoma: clinical features and molecular analysis. Acta Neurochir (Wien) 2009, 151(11):1349-1358. 10.1007/s00701-009-0387-1, 19730774.
15. Scheithauer BW, Fuller GN, VandenBerg SR. The 2007 WHO classification of tumors of the nervous system: controversies in surgical neuropathology. Brain Pathol 2008, 18(3):307-316. 10.1111/j.1750-3639.2008.00179.x, 18532929.
16. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352(10):987-996. 10.1056/NEJMoa043330, 15758009.
17. Devaux BC, O'Fallon JR, Kelly PJ. Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg 1993, 78(5):767-775. 10.3171/jns.1993.78.5.0767, 8468607.
18. Wang X, Liu YH, Xie F, You C, Mao Q. [A clinical and molecular study of long-term survival glioblastomas]. Zhonghua Wai Ke Za Zhi 2013, 51(2):166-170.
19. Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 2005, 64(6):479-489.
20. Parsa AT, Wachhorst S, Lamborn KR, Prados MD, McDermott MW, Berger MS, Chang SM. Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults. J Neurosurg 2005, 102(4):622-628. 10.3171/jns.2005.102.4.0622, 15871503.
21. Aguirre A, Gallo V. Postnatal neurogenesis and gliogenesis in the olfactory bulb from NG2-expressing progenitors of the subventricular zone. J Neurosci 2004, 24(46):10530-10541. 10.1523/JNEUROSCI.3572-04.2004, 15548668.
22. Chaichana KL, McGirt MJ, Frazier J, Attenello F, Guerrero-Cazares H, Quinones-Hinojosa A. Relationship of glioblastoma multiforme to the lateral ventricles predicts survival following tumor resection. J Neurooncol 2008, 89(2):219-224. 10.1007/s11060-008-9609-2, 18458819.
23. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ, . Group AL-GS Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006, 7(5):392-401. 10.1016/S1470-2045(06)70665-9, 16648043, Group AL-GS.